Biopharmaceutical leader in the development of treatments for rare diseases
Educated about reimbursement issues in Korea. Monitoring the implementation of the Patient Protection and Affordable Care Act, including provisions related to regulatory pathway for biosimilars and orphan drugs.
Education and outreach on treatment of rare diseases to Congressional staff.
Monitored deficit reduction initiatives related to enactment of an increase in the U.S. federal debt ceiling. Patent Reform
H.R. 1249 - America Invents Act of 2011
TRD - Trade (domestic/foreign) HCR - Health Issues CPT - Copyright/Patent/Trademark
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
W STRATEGIES, LLC
1455 Pennsylvania Avenue, NW, Suite 400, Washington, DC, 20004, US
DARREN WILLCOX DARREN WILLCOX DARREN WILLCOX